Wells Fargo’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,018
Closed -$18.1K 7410
2025
Q2
$18.1K Sell
2,018
-3,873
-66% -$23K ﹤0.01% 5808
2025
Q1
$31.7K Buy
5,891
+132
+2% +$897 ﹤0.01% 5549
2024
Q4
$42.9K Buy
5,759
+1,323
+30% +$10.9K ﹤0.01% 5539
2024
Q3
$40.1K Buy
4,436
+161
+4% +$1.66K ﹤0.01% 5423
2024
Q2
$45.4K Buy
4,275
+4,205
+6,007% +$44.8K ﹤0.01% 5337
2024
Q1
$617 Buy
70
+1
+1% +$8 ﹤0.01% 6243
2023
Q4
$471 Buy
69
+4
+6% +$33 ﹤0.01% 6397
2023
Q3
$634 Sell
65
-9
-12% -$72 ﹤0.01% 6313
2023
Q2
$358 Buy
74
+3
+4% +$13 ﹤0.01% 6553
2023
Q1
$285 Buy
71
+1
+1% +$4 ﹤0.01% 6676
2022
Q4
$270 Buy
70
+1
+1% +$5 ﹤0.01% 6539
2022
Q3
$0 Buy
69
+2
+3% +$9 ﹤0.01% 7405
2022
Q2
$0 Buy
67
+6
+10% +$30 ﹤0.01% 7526
2022
Q1
$0 Hold
61
﹤0.01% 7845
2021
Q4
$0 Hold
61
﹤0.01% 7834
2021
Q3
$0 Sell
61
-42
-41% -$338 ﹤0.01% 7544
2021
Q2
$1K Sell
103
-52,259
-100% -$450K ﹤0.01% 6747
2021
Q1
$434K Buy
52,362
+46,964
+870% +$333K ﹤0.01% 4757
2020
Q4
$35K Sell
5,398
-13,082
-71% -$82.6K ﹤0.01% 5705
2020
Q3
$109K Buy
18,480
+844
+5% +$5.54K ﹤0.01% 5228
2020
Q2
$124K Buy
17,636
+1,638
+10% +$12K ﹤0.01% 5132
2020
Q1
$83K Sell
15,998
-230
-1% -$1.57K ﹤0.01% 5155
2019
Q4
$120K Buy
16,228
+907
+6% +$7.52K ﹤0.01% 5213
2019
Q3
$132K Buy
15,321
+8,547
+126% +$73.1K ﹤0.01% 5191
2019
Q2
$54K Buy
+6,774
New +$61.6K ﹤0.01% 5523
2014
Q4
Sell
-12,200
Closed -$40K 6416
2014
Q3
$40K Buy
+12,200
New +$41.9K ﹤0.01% 5019
2014
Q1
Sell
-2,000
Closed -$7K 6083
2013
Q4
$7K Buy
+2,000
New +$7.47K ﹤0.01% 5274

Other funds holding ULBI

Wells Fargo's ULBI Position: Q3 2025 in Review

Wells Fargo sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 2,018 shares — an estimated $18.1K sold.

Wells Fargo first reported a position in ULBI in Q4 2013 and held it in 27 quarters. The position peaked at $434K in Q1 2021. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Wells Fargo reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 2,018 Ultralife shares in Q3 2025, an estimated $18.1K.
  • Wells Fargo first reported a position in Ultralife in Q4 2013 and held it in 27 quarters.
  • Wells Fargo's Ultralife position peaked at $434K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.